Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

Cordis, a Johnson and Johnson Company, ExoSeal(TM) 6F Vascular Closure Device, cat. No EX500, EX600, and EX700. Used for femoral artery puncture site closure, reducing times to hemostasis and ambulation in patients who have undergone diagnostic or interventional procedures.

FDA Recall Z-0740-2013 · Posted 2013-01-25

Recalling FirmCordis Corporation
Recall StatusTerminated
Product CodeMGB
Date Initiated2012-10-29
Date Terminated2013-11-06
Product Quantity98,675 units distributed in US.

Reason for Recall

Affected lots of Cordis ExoSeal (TM) VCD have been sterilized using a process that did not achieve the sterility assurance level that is required by the standards of this class of product. Model Numbers EX500, EX600, and EX700.

Firm Action

Cordis Corporation sent an "Urgent Medical Device Recall (Removal ) letter dated October 29, 2012, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer. Customers were instructed to immediately identify and set aside all product listed in a manner that ensures the affected product will not be used. A product recall response form was attached for customers to review, complete, sign and return the enclosed acknowledgement form directly to Cordis. For further questions please call (786) 313-2000.

Root Cause

Material/Component Contamination

Distribution Pattern

US (nationwide) including the states of AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NJ, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, WV and Hawaii.

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑